HU

Hugel, Inc.

Global provider of medical aesthetic solutions like botulinum toxin and HA fillers.

145020 | KO

Overview

Corporate Details

ISIN(s):
KR7145020004
LEI:
Country:
South Korea
Address:
강원특별자치도 춘천시 동내면 거두단지1길 23 -, 춘천시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Hugel, Inc. is a global biopharmaceutical company specializing in the medical aesthetics and therapeutics market. The company develops, manufactures, and sells a range of products, including its flagship botulinum toxin, hyaluronic acid (HA) fillers, skin boosters, and cosmetic threads. Recognized for its advanced technology, Hugel is a leading provider in the aesthetics field, having expanded its presence from its base in South Korea to major international markets such as the USA, Europe, and China. The company focuses on creating value in medical aesthetics by providing high-quality, scientifically-backed solutions for medical professionals and consumers.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-15 00:00
Board/Management Information
대표집행임원변경
Korean 12.6 KB
2025-09-15 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 14.7 KB
2025-09-12 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2025-08-29 00:00
Related Party Transaction
대규모기업집단현황공시[분기별공시(개별회사용)]
Korean 8.6 KB
2025-08-26 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 6.9 KB
2025-08-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-08-19 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 24.1 KB
2025-08-14 00:00
Regulatory News Service
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Korean 11.3 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 4.5 MB
2025-08-14 00:00
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.8 KB
2025-08-07 00:00
Regulatory News Service
풍문또는보도에대한해명(미확정)
Korean 11.8 KB
2025-08-06 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.7 KB
2025-08-06 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.1 KB
2025-08-06 00:00
Share Issue/Capital Change
[기재정정]주식매수선택권부여에관한신고
Korean 34.5 KB
2025-08-06 00:00
Transaction in Own Shares
주요사항보고서(자기주식처분결정)
Korean 30.2 KB

Automate Your Workflow. Get a real-time feed of all Hugel, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Hugel, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Hugel, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Enorama Pharma AB Logo
Develops & makes consumer nicotine products & medicated gums, offering private label solutions.
Sweden
ERMA
Ensysce Biosciences, Inc. Logo
Developing safer opioids with abuse-deterrent and overdose protection technology for severe pain.
United States of America
ENSC
Entera Bio Ltd. Logo
Developing oral versions of injectable drugs for osteoporosis, hypoparathyroidism, and obesity.
United States of America
ENTX
Entero Therapeutics, Inc. Logo
Develops targeted oral therapies for a range of gastrointestinal (GI) diseases.
United States of America
ENTO
Entrada Therapeutics, Inc. Logo
Developing intracellular therapeutics for rare neuromuscular diseases via its EEV™ platform.
United States of America
TRDA
Develops novel therapeutics and APIs for oncology, inflammation, and respiratory diseases.
South Korea
183490
Enzymatica AB Logo
Develops medical devices with patented enzyme technology to treat upper respiratory infections.
Sweden
ENZY
Developing alopecia therapies, skin regeneration products, and preclinical CRO services.
South Korea
446440
EQL Pharma AB Logo
Develops and sells cost-efficient niche generic medicines for the Nordic healthcare market.
Sweden
EQL
Equillium, Inc. Logo
Clinical-stage biotech creating therapies for severe autoimmune and inflammatory disorders.
United States of America
EQ

Talk to a Data Expert

Have a question? We'll get back to you promptly.